A detailed history of Blb&B Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Blb&B Advisors, LLC holds 38,160 shares of ABT stock, worth $3.94 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
38,160
Previous 38,049 0.29%
Holding current value
$3.94 Million
Previous $4.19 Million 3.56%
% of portfolio
0.25%
Previous 0.27%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 26, 2024

BUY
$109.52 - $120.96 $12,156 - $13,426
111 Added 0.29%
38,160 $4.34 Million
Q4 2023

Jan 19, 2024

SELL
$90.19 - $110.4 $45,455 - $55,641
-504 Reduced 1.31%
38,049 $4.19 Million
Q3 2023

Oct 24, 2023

SELL
$95.53 - $114.62 $43,466 - $52,152
-455 Reduced 1.17%
38,553 $3.73 Million
Q2 2023

Jul 20, 2023

SELL
$100.78 - $112.29 $22,776 - $25,377
-226 Reduced 0.58%
39,008 $4.25 Million
Q1 2023

Apr 21, 2023

SELL
$96.86 - $114.01 $80,296 - $94,514
-829 Reduced 2.07%
39,234 $3.97 Million
Q4 2022

Jan 17, 2023

SELL
$95.06 - $111.52 $67,777 - $79,513
-713 Reduced 1.75%
40,063 $0
Q3 2022

Oct 14, 2022

SELL
$96.76 - $112.03 $30,576 - $35,401
-316 Reduced 0.77%
40,776 $3.95 Million
Q2 2022

Jul 18, 2022

SELL
$102.07 - $123.37 $28,273 - $34,173
-277 Reduced 0.67%
41,092 $4.47 Million
Q1 2022

Apr 20, 2022

SELL
$114.02 - $139.04 $217,778 - $265,566
-1,910 Reduced 4.41%
41,369 $4.9 Million
Q4 2021

Jan 21, 2022

SELL
$115.53 - $141.46 $608,496 - $745,069
-5,267 Reduced 10.85%
43,279 $6.09 Million
Q3 2021

Oct 19, 2021

BUY
$116.66 - $129.06 $87,844 - $97,182
753 Added 1.58%
48,546 $5.74 Million
Q2 2021

Jul 20, 2021

BUY
$105.79 - $124.53 $27,928 - $32,875
264 Added 0.56%
47,793 $5.54 Million
Q1 2021

Apr 19, 2021

SELL
$108.84 - $128.23 $695,922 - $819,902
-6,394 Reduced 11.86%
47,529 $5.7 Million
Q4 2020

Jan 19, 2021

BUY
$105.0 - $114.42 $181,440 - $197,717
1,728 Added 3.31%
53,923 $5.9 Million
Q3 2020

Oct 20, 2020

SELL
$91.64 - $111.29 $59,382 - $72,115
-648 Reduced 1.23%
52,195 $5.68 Million
Q2 2020

Jul 16, 2020

SELL
$76.57 - $98.0 $237,137 - $303,506
-3,097 Reduced 5.54%
52,843 $4.83 Million
Q1 2020

Apr 21, 2020

SELL
$62.82 - $91.86 $203,097 - $296,983
-3,233 Reduced 5.46%
55,940 $4.41 Million
Q4 2019

Jan 21, 2020

SELL
$78.51 - $87.4 $69,873 - $77,786
-890 Reduced 1.48%
59,173 $5.14 Million
Q3 2019

Oct 22, 2019

SELL
$81.84 - $88.74 $31,753 - $34,431
-388 Reduced 0.64%
60,063 $5.03 Million
Q2 2019

Jul 29, 2019

SELL
$72.88 - $85.0 $133,006 - $155,125
-1,825 Reduced 2.93%
60,451 $5.08 Million
Q1 2019

Apr 19, 2019

SELL
$66.22 - $80.06 $182,899 - $221,125
-2,762 Reduced 4.25%
62,276 $4.98 Million
Q4 2018

Jan 17, 2019

SELL
$65.56 - $74.27 $152,820 - $173,123
-2,331 Reduced 3.46%
65,038 $4.7 Million
Q3 2018

Oct 12, 2018

SELL
$60.81 - $73.36 $293,529 - $354,108
-4,827 Reduced 6.69%
67,369 $4.94 Million
Q2 2018

Jul 11, 2018

SELL
$57.57 - $63.54 $10,650 - $11,754
-185 Reduced 0.26%
72,196 $4.4 Million
Q1 2018

Apr 09, 2018

SELL
$56.27 - $63.62 $118,279 - $133,729
-2,102 Reduced 2.82%
72,381 $4.34 Million
Q4 2017

Jan 16, 2018

BUY
$53.68 - $57.47 $55,612 - $59,538
1,036 Added 1.41%
74,483 $4.25 Million
Q3 2017

Oct 16, 2017

BUY
$48.06 - $53.64 $3.53 Million - $3.94 Million
73,447
73,447 $3.92 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $181B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Blb&B Advisors, LLC Portfolio

Follow Blb&B Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blb&B Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blb&B Advisors, LLC with notifications on news.